Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript

Page 5 of 5

Operator: Thank you. We’ve reached the end of our question-and-answer session. I’d like to turn the floor back over to Steve for any further or closing comments.

Stephen Yoder: Okay. Well, thank you, Kevin. And I want to thank everyone again today for your attention and for your continued support of the company. We are truly excited by the promise in particular of our inhaled biologics pipeline and the opportunity to improve outcomes for patients with respiratory disease. We look forward to updating you on our progress. Have a great day.

Operator: Thank you. That does conclude today’s teleconference and webcast. You may disconnect your line at this time and have a wonderful day. We thank you for your participation today.

Follow Palvella Therapeutics Inc. (NYSE:PVLA)

Page 5 of 5